Open evaluation of the efficacy and endoscopic gastric tolerance of proglumetacin in chronic rheumatic in-patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects*; D005756:Gastritis / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D007210:Indoleacetic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007210:Indoleacetic Acids; D010879:Piperazines; C019541:proglumetacin